Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens

BACKGROUND: Chemotherapy options in patients with advanced pancreatic ductal adenocarcinoma (PDAC) after failure of standard chemotherapies are limited. OBJECTIVES: We aimed to report the efficacy and safety of the leucovorin and 5-fluorouracil (LV5FU2) and carboplatin combination in this setting. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaigneau, Thomas, Aguilera Munoz, Lina, Oger, Caroline, Gourdeau, Clémence, Hentic, Olivia, Laurent, Lucie, Muller, Nelly, Dioguardi Burgio, Marco, Gagaille, Marie-Pauline, Lévy, Philippe, Rebours, Vinciane, Hammel, Pascal, de Mestier, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052496/
https://www.ncbi.nlm.nih.gov/pubmed/37007630
http://dx.doi.org/10.1177/17588359231163776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052496/
https://www.ncbi.nlm.nih.gov/pubmed/37007630
http://dx.doi.org/10.1177/17588359231163776

Ejemplares similares